文献速递鼻科头颈外科

颅面恶性血管周上皮样细胞肿瘤:罕见表现文献综述

Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation.
PubMed 文献 · Head Neck · 2025-12-10

本文报告首例可能的鼻窦道高级别恶性血管周上皮样细胞肿瘤(PEComa),伴前颅底和眶侵犯。患者为42岁女性,携带种系RB1突变,婴儿期因双侧视网膜母细胞瘤接受放疗,并有左侧鼻窦道平滑肌肉瘤病史。文献回顾共识别41例既往报告的颅面PEComa,其中51%位于鼻窦道、37%位于眶、10%位于颅底,几乎所有病例均为良性并接受手术切除。

要点

  • 颅面PEComa极罕见,多数良性,手术切除为主要治疗。
  • 本例为恶性PEComa,伴眶和颅底广泛侵犯,进展异常迅速。
  • 既往放疗和种系RB1突变可能促进本例肿瘤快速进展。

核心结论

  • 本文报告一例罕见的恶性颅面PEComa,伴眶和颅底广泛侵犯,扩展了该类肿瘤的临床和分子谱。

研究设计与样本

  • 病例报告联合文献综述:报告首例可能的鼻窦道高级别恶性PEComa,并回顾既往报告的41例原发性颅面PEComa。

主要发现

  • 患者为42岁女性,携带种系RB1突变,婴儿期因双侧视网膜母细胞瘤接受放疗,并有左侧鼻窦道平滑肌肉瘤治疗史。
  • 六年后再发对侧鼻出血和右侧鼻腔易碎肿块,内镜和影像学证实局部侵袭性病变。
  • 组织病理学显示高度增殖性肿瘤,免疫组化HMB45、melan-A、SMA、caldesmon和TFE3阳性,desmin和MITF缺失,符合恶性PEComa。
  • 肿瘤经经颅、经泪阜和鼻内镜联合入路切除,切缘阴性。
  • 文献回顾的41例颅面PEComa中,51%位于鼻窦道、37%位于眶、10%位于颅底,几乎所有病例为良性并接受手术切除。

临床怎么用

  • 颅面PEComa的诊断需结合组织病理学和免疫组化(HMB45、melan-A、SMA、caldesmon、TFE3等)。
  • 手术切除是颅面PEComa的主要治疗方式,恶性病例需争取切缘阴性。
  • 对于有RB1突变和既往放疗史的患者,应警惕PEComa恶性进展的可能。

局限性

  • 本文为单例病例报告和文献综述,证据级别有限。
  • 文献回顾中既往病例几乎均为良性,恶性病例的临床行为数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with smooth muscle and melanocytic differentiation, typically occurring in genitourinary or abdominopelvic sites. While multiple anatomic sites have been reported, craniofacial involvement is exceptionally rare. METHODS: We report the first documented case of a probable high-grade malignant PEComa of the sinonasal tract with anterior skull base and orbital extension. The patient was a 42-year-old woman with a germline RB1 mutation, prior radiotherapy for bilateral retinoblastoma as an infant, and a history of left-sided sinonasal leiomyosarcoma treated with surgical resection and anthracycline chemotherapy. She represented six years later with new contralateral epistaxis and a friable right-sided nasal mass. Upon endoscopy and imaging, a locally aggressive lesion was confirmed. RESULTS: Histopathology showed a highly proliferative tumor with immunohistochemistry positive for HMB45, melan-A, SMA, caldesmon, and TFE3, with absent desmin and MITF. The lesion was most in keeping with a malignant PEComa. The tumor was resected via a combined transcranial, transcaruncular, and endoscopic endonasal approach, achieving clear margins. This case shows unusually rapid progression, likely influenced by prior radiation and germline RB1 gene mutation. Our literature review identified 41 previously reported primary craniofacial PEComas, consisting of 51% sinonasal, 37% orbital, and 10% skull base. Nearly all cases were benign and treated with surgical resection. CONCLUSIONS: This report highlights a rare, malignant craniofacial PEComa with extensive invasion into the orbit and skull base, expanding the known clinical and molecular spectrum of these tumors.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Paris J, Abdullah A, Ang T, et al. Malignant Craniofacial Perivascular Epithelioid Cell Tumor: A Review of Literature With a Rare Presentation. Head Neck. 2025. PMID: 41367329. doi:10.1002/hed.70126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。